Sun Pharma’s New GLP-1 Drug for the U.S. A Game-Changer in Diabetes & Weight Loss Market
The global pharmaceutical industry is witnessing a massive shift with the rise of GLP-1 receptor agonists, a class of drugs transforming the treatment of type 2 diabetes and obesity. Among the key players, Sun Pharma is making strategic moves to enter this high-growth segment—especially targeting the U.S. market. In this blog, we’ll break down Sun … Read more